Harrington KJ - Search Results

1

Cancer gene therapy: developments to 2000.

Bateman AR, Harrington KJ, Melcher AA, Vile RG. Bateman AR, et al. Among authors: harrington kj. Expert Opin Investig Drugs. 2000 Dec;9(12):2799-813. doi: 10.1517/13543784.9.12.2799. Expert Opin Investig Drugs. 2000. PMID: 11093354 Review.

2

Risk factors for pneumothorax during percutaneous Hickman line insertion in patients with solid and haematological tumours.

Harrington KJ, Pandha HS, Hollyer JS, Kelly SA, Bateman AR, Lewanski C, Morris P, Jackson JE. Harrington KJ, et al. Clin Oncol (R Coll Radiol). 1995;7(6):373-6. doi: 10.1016/s0936-6555(05)80008-1. Clin Oncol (R Coll Radiol). 1995. PMID: 8590699

3

Cancer-related thromboembolic disease in patients with solid tumours: a retrospective analysis.

Harrington KJ, Bateman AR, Syrigos KN, Rintoul R, Bhidayasiri R, McCormack M, Thomas H. Harrington KJ, et al. Ann Oncol. 1997 Jul;8(7):669-73. doi: 10.1023/a:1008230706660. Ann Oncol. 1997. PMID: 9296220 Free article.

4

Pegylated liposomes have potential as vehicles for intratumoral and subcutaneous drug delivery.

Harrington KJ, Rowlinson-Busza G, Syrigos KN, Uster PS, Vile RG, Stewart JS. Harrington KJ, et al. Clin Cancer Res. 2000 Jun;6(6):2528-37. Clin Cancer Res. 2000. PMID: 10873109

5

Transcriptional control: an essential component of cancer gene therapy strategies?

Harrington KJ, Linardakis E, Vile RG. Harrington KJ, et al. Adv Drug Deliv Rev. 2000 Nov 15;44(2-3):167-84. doi: 10.1016/s0169-409x(00)00093-4. Adv Drug Deliv Rev. 2000. PMID: 11072113 Review.

6

Viral fusogenic membrane glycoprotein expression causes syncytia formation with bioenergetic cell death: implications for gene therapy.

Higuchi H, Bronk SF, Bateman A, Harrington K, Vile RG, Gores GJ. Higuchi H, et al. Cancer Res. 2000 Nov 15;60(22):6396-402. Cancer Res. 2000. PMID: 11103804

7

Pegylated liposome-encapsulated doxorubicin and cisplatin enhance the effect of radiotherapy in a tumor xenograft model.

Harrington KJ, Rowlinson-Busza G, Syrigos KN, Vile RG, Uster PS, Peters AM, Stewart JS. Harrington KJ, et al. Clin Cancer Res. 2000 Dec;6(12):4939-49. Clin Cancer Res. 2000. PMID: 11156255

8

Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes.

Harrington KJ, Mohammadtaghi S, Uster PS, Glass D, Peters AM, Vile RG, Stewart JS. Harrington KJ, et al. Clin Cancer Res. 2001 Feb;7(2):243-54. Clin Cancer Res. 2001. PMID: 11234875

9

Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model.

Harrington KJ, Rowlinson-Busza G, Uster PS, Vile RG, Peters AM, Stewart JS. Harrington KJ, et al. Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1141-8. doi: 10.1016/s0360-3016(00)01444-9. Int J Radiat Oncol Biol Phys. 2001. PMID: 11240257

10

The effect of irradiation on the biodistribution of radiolabeled pegylated liposomes.

Harrington KJ, Rowlinson-Busza G, Syrigos KN, Uster PS, Vile RG, Peters AM, Stewart JS. Harrington KJ, et al. Int J Radiat Oncol Biol Phys. 2001 Jul 1;50(3):809-20. doi: 10.1016/s0360-3016(01)01508-5. Int J Radiat Oncol Biol Phys. 2001. PMID: 11395251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

421 results

Search Page

Filters